SHORT MINI-FUTURE - SARTORIUS VZ Stock

Certificat

DE000VX5EA02

Delayed Deutsche Boerse AG 10:40:06 2024-05-21 EDT
33.53 EUR 0.00% Intraday chart for SHORT MINI-FUTURE - SARTORIUS VZ
Current month+4.13%
1 month+0.33%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-05-21 33.53 0.00%
24-05-20 33.53 -0.24%
24-05-17 33.61 +3.00%
24-05-16 32.63 +4.58%
24-05-15 31.2 -1.64%

Delayed Quote Deutsche Boerse AG

Last update May 21, 2024 at 10:40 am

More quotes

Static data

Product typeKnock-Out with Stop Loss
Buy / SellPUT
Underlying SARTORIUS AG
IssuerLogo Issuer Vontobel Vontobel
WKN VX5EA0
ISINDE000VX5EA02
Date issued 2022-01-04
Strike 605.2
Maturity Unlimited
Parity 10 : 1
Emission price 3.52
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 38.68
Lowest since issue 6.82
Spread 0.03
Spread %0.09%

Company Profile

Sartorius AG is a Germany-based supplier of pharmaceutical and laboratory equipment. It operates in two segments: bioprocess solutions and lab products and services. The bioprocess solutions segment offers integrated solutions for biopharmaceutical manufacture, such as filters for sterilization of biopharmaceutical media, single-use bags for cell cultivation and storage of biopharmaceuticals, membrane adsorbers for purification in bioprocesses, filter technology for clarification, among others. The lab Products and Services segment provides instruments, consumables, and services for laboratories, including laboratory balances, laboratory water systems for storage of purified water, electronic pipettes, filter systems for sample preparation, and membrane filter systems for sterility testing of parenteral.
Sector
-
More about the company

Ratings for Sartorius AG

Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings

Consensus: Sartorius AG

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
270 EUR
Average target price
326.8 EUR
Spread / Average Target
+21.02%
Consensus
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW